发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Drugs for COPD. 慢性阻塞性肺病药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-09-02 DOI: 10.58347/tml.2024.1710a
{"title":"Drugs for COPD.","authors":"","doi":"10.58347/tml.2024.1710a","DOIUrl":"10.58347/tml.2024.1710a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ganaxolone (Ztalmy) for CDKL5 deficiency disorder. 治疗 CDKL5 缺乏症的甘纳昔龙（Ztalmy）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-08-19 DOI: 10.58347/tml.2024.1709g
{"title":"Ganaxolone (Ztalmy) for CDKL5 deficiency disorder.","authors":"","doi":"10.58347/tml.2024.1709g","DOIUrl":"10.58347/tml.2024.1709g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Expanded indication for Elevidys. 简而言之扩大 Elevidys 的适应症。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-08-19 DOI: 10.58347/tml.2024.1709e
{"title":"In brief: Expanded indication for Elevidys.","authors":"","doi":"10.58347/tml.2024.1709e","DOIUrl":"10.58347/tml.2024.1709e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table: GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes. 表：治疗 2 型糖尿病的 GLP-1 和 GIP/GLP-1 受体激动剂。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-08-05 DOI: 10.58347/tml.2024.1708c
{"title":"Table: GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes.","authors":"","doi":"10.58347/tml.2024.1708c","DOIUrl":"https://doi.org/10.58347/tml.2024.1708c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table: Amyloid-directed antibodies for Alzheimer's disease. 表格：治疗阿尔茨海默病的淀粉样蛋白定向抗体。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-08-05 DOI: 10.58347/tml.2024.1708e
{"title":"Table: Amyloid-directed antibodies for Alzheimer's disease.","authors":"","doi":"10.58347/tml.2024.1708e","DOIUrl":"https://doi.org/10.58347/tml.2024.1708e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table: GLP-1 and GIP/GLP-1 receptor agonists for chronic weight management. 表：用于慢性体重管理的 GLP-1 和 GIP/GLP-1 受体激动剂。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-08-05 DOI: 10.58347/tml.2024.1708d
{"title":"Table: GLP-1 and GIP/GLP-1 receptor agonists for chronic weight management.","authors":"","doi":"10.58347/tml.2024.1708d","DOIUrl":"https://doi.org/10.58347/tml.2024.1708d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brella Sweat Control Patch for primary axillary hyperhidrosis. 用于治疗原发性腋窝多汗症的 Brella 控汗贴。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-07-22 DOI: 10.58347/tml.2024.1707i
{"title":"Brella Sweat Control Patch for primary axillary hyperhidrosis.","authors":"","doi":"10.58347/tml.2024.1707i","DOIUrl":"https://doi.org/10.58347/tml.2024.1707i","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nifurtimox (Lampit) for Chagas disease. 治疗南美锥虫病的 Nifurtimox（Lampit）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-07-22 DOI: 10.58347/tml.2024.1707h
{"title":"Nifurtimox (Lampit) for Chagas disease.","authors":"","doi":"10.58347/tml.2024.1707h","DOIUrl":"https://doi.org/10.58347/tml.2024.1707h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for postmenopausal osteoporosis. 治疗绝经后骨质疏松症的药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-07-08 DOI: 10.58347/tml.2024.1706a
{"title":"Drugs for postmenopausal osteoporosis.","authors":"","doi":"10.58347/tml.2024.1706a","DOIUrl":"10.58347/tml.2024.1706a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trofinetide (Daybue) for Rett syndrome. 治疗雷特综合征的特罗菲奈德（Daybue）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-07-08 DOI: 10.58347/tml.2024.1706d
{"title":"Trofinetide (Daybue) for Rett syndrome.","authors":"","doi":"10.58347/tml.2024.1706d","DOIUrl":"10.58347/tml.2024.1706d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信